These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25304067)

  • 1. Lowering furosemide dose in stable chronic heart failure patients with reduced ejection fraction is not accompanied by decompensation: a randomized study.
    Kapelios CJ; Kaldara E; Ntalianis A; Nana E; Pantsios C; Repasos E; Margari Z; Sousonis V; Malliaras K; Nanas JN
    Int J Cardiol; 2014 Dec; 177(2):690-2. PubMed ID: 25304067
    [No Abstract]   [Full Text] [Related]  

  • 2. Lowering of furosemide dosage after clinical stabilization in patients with congestive heart failure.
    Alexopoulos GP; Anastasiou-Nana MI; Rapti ACh; Margari ZJ; Terrovitis JV; Mitsibounas D; Makri S; Nanas JN
    Acta Cardiol; 2003 Dec; 58(6):513-7. PubMed ID: 14713176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
    Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
    Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic implications of outpatient diuretic dose in heart failure.
    Harjai KJ; Dinshaw HK; Nunez E; Shah M; Thompson H; Turgut T; Ventura HO
    Int J Cardiol; 1999 Dec; 71(3):219-25. PubMed ID: 10636527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
    Allen LA; Turer AT; Dewald T; Stough WG; Cotter G; O'Connor CM
    Am J Cardiol; 2010 Jun; 105(12):1794-7. PubMed ID: 20538132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction.
    Takei M; Kohsaka S; Shiraishi Y; Goda A; Izumi Y; Yagawa M; Mizuno A; Sawano M; Inohara T; Kohno T; Fukuda K; Yoshikawa T;
    Circ Heart Fail; 2015 May; 8(3):527-32. PubMed ID: 25737498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure.
    Chuen MJ; MacFadyen RJ
    Am J Cardiol; 2006 Nov; 98(10):1416-7. PubMed ID: 17134642
    [No Abstract]   [Full Text] [Related]  

  • 10. Subcutaneous infusion of furosemide administered by elastomeric pumps for decompensated heart failure treatment: initial experience.
    Zatarain-Nicolás E; López-Díaz J; de la Fuente-Galán L; García-Pardo H; Recio-Platero A; San Román-Calvar JA
    Rev Esp Cardiol (Engl Ed); 2013 Dec; 66(12):1002-4. PubMed ID: 24774118
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of Compound Hypertonic Saline Solution on Decompensated Heart Failure.
    Wan Y; Li L; Niu H; Ma X; Yang J; Yuan C; Mu G; Zhang J
    Int Heart J; 2017 Aug; 58(4):601-607. PubMed ID: 28701670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of diuretic dose in chronic heart failure.
    Martins J; Lourenço P; Araújo JP; Mascarenhas J; Lopes R; Azevedo A; Bettencourt P
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):185-91. PubMed ID: 21335479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Furosemide in acute decompensated heart failure.
    Prescrire Int; 2012 Dec; 21(133):303. PubMed ID: 23373103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial.
    da Rosa PR; Rohde LE; Doebber M; Ribeiro ALP; Prado DP; Bertoldi EG; Figueiredo Neto JA; Kohler I; Beck-da-Silva L; Danzmann LC; Moura LZ; Rover M; Simões MV; Sant'Anna RT; Biolo A
    Am Heart J; 2017 Dec; 194():125-131. PubMed ID: 29223430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions.
    Mouallem M; Brif I; Mayan H; Farfel Z
    Int J Cardiol; 1995 Jun; 50(2):89-94. PubMed ID: 7591335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization.
    Abdel-Qadir HM; Tu JV; Yun L; Austin PC; Newton GE; Lee DS
    Am Heart J; 2010 Aug; 160(2):264-271.e1. PubMed ID: 20691831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
    Ng TM; Hshieh S; Chan CY; Elkayam U
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrafiltration in heart failure with preserved ejection fraction: comparison with systolic heart failure patients.
    Jefferies JL; Bartone C; Menon S; Egnaczyk GF; O'Brien TM; Chung ES
    Circ Heart Fail; 2013 Jul; 6(4):733-9. PubMed ID: 23735537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
    Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
    Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.